Cite
HARVARD Citation
Petrini, M. et al. (2022). Safety and Efficacy of Subcutaneous Rituximab in Previously Untreated Patients with CD20+ Diffuse Large B-Cell Lymphoma or Follicular Lymphoma: Results from an Italian Phase IIIb Study. Advances in hematology. p. . [Online].